Fortical

Fortical is a brand name of calcitonin, approved by the FDA in the following formulation(s):

FORTICAL (calcitonin salmon recombinant - spray, metered; nasal)

• 
  Manufacturer: UPSHER SMITH
  
  Approval date: August 12, 2005
  
  Strength(s): 200 IU/SPRAY ^[RLD]

Has a generic version of Fortical been approved?

No. There is currently no therapeutically equivalent version of Fortical available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Fortical. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Nasal calcitonin formulations
  Patent 6,440,392
  Issued: August 27, 2002
  Inventor(s): William; Stern
  Assignee(s): Unigene Laboratories, Inc.
  A liquid pharmaceutical composition is disclosed comprising calcitonin or an acid addition salt thereof and citric acid or salt thereof in a concentration from about to about 50 mM, said composition being in a form table for nasal administration.
  
  Patent expiration dates:
  
  
  • February 2, 2021
    
    ✓ 
    Patent use: NASAL ADMINISTRATION
    ✓ 
    Drug product
  
  



• 
  Nasal calcitonin formulation
  Patent RE40812
  Issued: June 30, 2009
  Inventor(s): Stern; William
  Assignee(s): Unigene Laboratories Inc.
  A liquid pharmaceutical composition is disclosed comprising calcitonin or an acid addition salt thereof and citric acid or salt thereof in a concentration from about to about 50 mM, said composition being in a form table for nasal administration. A liquid pharmaceutical composition is provided for nasal administration of calcitonin or an acid addition salt thereof. The nasal pharmaceutical formulations contain a component selected from the group consisting of citric acid, citric acid salt and a combination thereof.
  
  Patent expiration dates:
  
  
  • February 2, 2021
    
    ✓ 
    Drug product
  
  

See also...

• Fortical Consumer Information (Drugs.com)
• Fortical Spray Consumer Information (Wolters Kluwer)
• Fortical Consumer Information (Cerner Multum)
• Fortical Nasal Advanced Consumer Information (Micromedex)
• Fortical Parenteral Advanced Consumer Information (Micromedex)
• Calcitonin Salmon Spray Consumer Information (Wolters Kluwer)
• Calcitonin-Salmon Consumer Information (Wolters Kluwer)
• Calcitonin injection Consumer Information (Cerner Multum)
• Calcitonin nasal Consumer Information (Cerner Multum)
• Calcitonin (salmon) Nasal Advanced Consumer Information (Micromedex)
• Calcitonin Injection Advanced Consumer Information (Micromedex)
• Calcitonin Nasal Advanced Consumer Information (Micromedex)
• Calcitonin Parenteral Advanced Consumer Information (Micromedex)
• Calcitonin AHFS DI Monographs (ASHP)